| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |